Todos os estudos
Ativo, mas não recrutandoFASE2INTERVENCIONISTA

A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema

Hereditary angioedema (HAE) is a rare genetic condition that causes sudden, painful swelling in different parts of the body, such as the hands, feet, face, gut, or throat. This Phase 2 clinical trial is testing a new preventive medicine called STAR-0215. The main goal is to find out how safe STAR-0215 is and how well it stops swelling attacks when taken over a longer period. The trial is open to adults aged 18 and older with Type 1 or Type 2 HAE. This includes people who took part in an earlier study of the drug, as well as those who have never tried it before. Participants will receive repeat doses of STAR-0215 for up to five years. Throughout the study, doctors will closely monitor each person to see if the medicine offers lasting protection and helps improve day-to-day life.

Em resumo

Status
Ativo, mas não recrutando
Fase
FASE2
Patrocinador
Astria Therapeutics, Inc.
Meta de inscrição
56
Iniciar
26 Sep 2023
Conclusão estimada
01 Mar 2031

Sobre o que é este estudo?

Hereditary angioedema (HAE) is a lifelong genetic condition that causes blood vessels to leak fluid into nearby tissues. This leads to unpredictable swelling attacks that can be very painful and disruptive. If the swelling happens in the throat, it can even become an emergency. Finding reliable treatments that can prevent these attacks before they start is a key priority for doctors and patients alike.

This study focuses on an experimental medicine called STAR-0215. It is designed to act as a preventative treatment, meaning it aims to stop attacks from happening in the first place rather than treating them after they begin. Researchers have already started testing STAR-0215, but they now need to understand how the body handles the medicine over a much longer timeframe.

Over the course of up to five years, researchers will gather vital information about the safety of repeat doses and how well the treatment prevents attacks over time. Long-term studies like this are crucial for rare diseases, as they provide the evidence needed to show whether a new therapy is safe and effective for ongoing, everyday use.

Pontos principais

  • Tests an experimental preventative medicine called STAR-0215 for hereditary angioedema.
  • Open to adults aged 18 and older with Type 1 or Type 2 HAE.
  • Participants may receive treatment for up to five years to assess long-term safety.
  • Welcomes both new participants and those who took part in the earlier STAR-0215 study.
  • Taking part is completely voluntary and you can leave at any time.

Quem pode ser elegível?

This trial is open to adults aged 18 and over who have a confirmed diagnosis of Type 1 or Type 2 hereditary angioedema. You may be able to join if you took part in the previous STAR-0215 trial, or if you have never received this study medicine before.

You will not be able to take part if you have other types of swelling conditions, such as swelling linked to hives or Type 3 HAE. Because certain medicines can trigger attacks or interfere with the study, you cannot join if you have recently taken blood pressure medicines called ACE inhibitors, or therapies containing oestrogen (such as certain contraceptive pills or HRT).

You also cannot join if you have recently taken androgen steroids, or certain other preventative HAE drugs like lanadelumab or berotralstat, without an agreed break beforehand. The study doctor can check the timing of your current medications to see if you qualify.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. I am at least 18 years old.
  2. I have been diagnosed by a doctor with Type 1 or Type 2 hereditary angioedema.
  3. I do not have swelling caused by hives (urticaria) or Type 3 HAE.
  4. I have not recently used ACE inhibitor blood pressure pills or medicines containing oestrogen.
  5. I am willing to attend regular clinic check-ups over a long-term period.
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

Taking part in this trial involves receiving repeat doses of the study medicine, STAR-0215, over a period of up to five years. You will need to visit a study clinic regularly so the medical team can check on your health and give you your treatment. During these visits, the team will perform routine tests, such as taking blood and urine samples, checking your vital signs, and doing physical examinations. You will also be asked to keep a record of any swelling attacks you experience between visits. The trial team will support you throughout the entire study to monitor how you are feeling.

Riscos e benefícios potenciais

Taking part may help reduce how often you get swelling attacks, but there is no guarantee that the medicine will work for you. By joining, you will also be helping doctors learn more about managing HAE, which could benefit others in the future. As with any new medicine, there is a risk of side effects, such as pain or redness where the injection is given, or other unexpected reactions. Your safety is closely tracked at every visit. Taking part is completely your choice, and you are free to leave the trial at any point without it affecting your normal medical care.

Localizações (22)

  • Pesquisa Clínica Allervie
    Código postal verificado
    Birmingham, Estados Unidos
  • Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD
    Código postal verificado
    Scottsdale, Estados Unidos
  • Acuro Research
    Código postal verificado
    Little Rock, Estados Unidos
  • UC San Diego US HAEA Angioedema Center
    Código postal verificado
    San Diego, Estados Unidos
  • Raffi Tachdjian MD, Inc
    Código postal verificado
    Santa Monica, Estados Unidos
  • Allergy & Asthma Clinical Research
    Código postal verificado
    Walnut Creek, Estados Unidos
  • Institute for Asthma and Allergy, PC
    Código postal verificado
    Chevy Chase, United States
  • Hospital Geral de Massachusetts
    Código postal verificado
    Boston, Estados Unidos
  • Faculdade de Medicina da Universidade de Washington
    Código postal verificado
    St Louis, Estados Unidos
  • Optimed Research
    Código postal verificado
    Columbus, Estados Unidos
  • Penn State Health Milton S. Hershey Medical Center
    Código postal verificado
    Hershey, Estados Unidos
  • AARA Research Center
    Código postal verificado
    Dallas, Estados Unidos

Perguntas frequentes

What is the main purpose of this trial?

The study aims to see how safe STAR-0215 is and how well it prevents swelling attacks when taken regularly for up to five years.

Do I have to have taken STAR-0215 before to join?

No. The trial welcomes people who were in an earlier study of STAR-0215, as well as people who have never received the medicine before.

Will I have to stop my current HAE medications?

Certain long-term preventative treatments cannot be used during the trial. The study team will explain whether you need a break from your usual medicines and what rescue treatments you can use for sudden attacks.

Can I leave the study early if I want to?

Yes. Joining a clinical trial is entirely voluntary. You can stop taking part at any time, for any reason, and your regular doctor will continue your standard care.

Does it cost anything to take part?

No. The study treatment and all trial-related medical tests are provided free of charge, and trial visits are covered by the study organisers.

Como saber mais

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.